All In MedTech

Device Trial Radar · NCT04849169

Investigation of the Ringer Perfusion Balloon Catheter

A Prospective, Multicenter, Single-arm Investigation of the Ringer Perfusion Balloon Catheter Performed Under an Exception From Informed Consent (EFIC) (Ringer IDE Study)

Last checked: Nov 20, 2026Latest source record: Dec 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Jul 18, 2022

Primary completion

Nov 21, 2023

Study completion Nov 21, 2023

Sponsor

Lead sponsor
Vascular Solutions LLCNot on our public-company list
Sponsor type
Industry
First posted
Apr 19, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to demonstrate reasonable assurance that the Ringer catheter can be safely used to manage hemorrhage due to coronary vessel perforations while facilitating distal perfusion under the conditions of use prescribed in the labeling.

Conditions

  • Coronary Artery Perforation

Interventions

  • ExperimentalDevice

    Prolonged balloon inflation for hemorrhage management due to coronary artery perforation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effectiveness of device success in managing hemorrhage while preserving flowTime frame: Procedure

1 more outcomes with a free account

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Piedmont Heart Institute

    Atlanta, Georgia

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.